ACE and chronic obstructive pulmonary disease: In addition, there were significant differences in sex, COPD index year, monthly income, medications for hypertension (beta-blockers, angiotensin-converting- enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs), medications for COPD and statins between the two groups.